| NCT ID | NCT04443179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King's College London |
| Condition | Autism Spectrum Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 790 participants |
| Start Date | 2013-04-05 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 790 participants in total. It began in 2013-04-05 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of the BIBS Study The Brain Imaging in Babies study (BIBS) aims to improve understanding of how a baby's brain develops from before birth, up until 3-4 years of age. Working with children from a variety of backgrounds and communities, the investigators use a combination of state-of-the-art diagnostic tools such as MRI scans alongside traditional behavioural assessments to capture the earliest information on infant brain development. The focus of the BIBS study MRI scanning is a safe way of producing detailed images using strong magnetic fields and radio waves. It does not use X-ray. Along with learning more about brain development in general, the investigators also try to identify features that may in future help predict whether a child will or will not develop traits of conditions such as Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD). Long-term, this may help target useful interventions early on, helping children who are most in need. Since COVID-19 arrived in the United Kingdom (U.K.) in 2020, the investigators have been given ethical approval to include testing for this infection in the mothers and children participating in the study. This may provide an opportunity to better understand how mother and baby respond to infections. The investigators particularly welcome mothers who have had a positive COVID-19 test during their pregnancy to join the study.
Eligibility Criteria
Inclusion Criteria: * Pregnant mothers with and without confirmed COVID-19 * Infants with and without an immediate family history of Autism Spectrum and neurodevelopmental conditions * Based in England, UK Exclusion Criteria: * based on further screening
Frequently Asked Questions
Who can join the NCT04443179 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 75 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04443179 currently recruiting?
Yes, NCT04443179 is actively recruiting participants. Visit ClinicalTrials.gov or contact King's College London to inquire about joining.
Where is the NCT04443179 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT04443179 clinical trial?
NCT04443179 is sponsored by King's College London. The trial plans to enroll 790 participants.